Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 7,084,130 protect, and when does it expire?

Patent ► Subscribe protects NAVSTEL and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: ► Subscribe

Title:	Intraocular irrigating solution having improved flow characteristics
Abstract:	Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Inventor(s):	Shah; Mandar V. (Arlington, TX), Boukhny; Mikhail (Laguna Niguel, CA), Garner; William H. (Southlake, TX), Markwardt; Kerry L. (Mansfield, TX), Doshi; Uday (Randolph, NJ)
Assignee:	Alcon, Inc. (Hunenberg, CH)
Application Number:	10/240,449
Patent Claim Types: see list of patent claims	Composition; Formulation; Use;

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	RS	Patent No.	Patent Expiration	Product	Patented / Exclusive Use
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	DISCN	No	No	► Subscribe	► Subscribe	Y	USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

PCT Information
PCT Filed	December 11, 2001	PCT Application Number:	PCT/US01/48094
PCT Publication Date:	June 27, 2002	PCT Publication Number:	WO02/49614

International Patent Family for Patent: ► Subscribe

Country	Document Number	Estimated Expiration
Austria	459337	► Subscribe
Australia	2002239601	► Subscribe
Australia	3960102	► Subscribe
Brazil	0116353	► Subscribe
Canada	2431368	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

DrugPatentWatch Database Preview